AIMatMelanoma
AIMatMelanoma
  • 762
  • 823 350
NeoAdjuvant & Adjuvant Therapy: Questions Getting Answered
Sapna Patel, MD
Chair SWOG Melanoma Committee, University of Colorado
Dr. William Robinson Endowed Chair, Professor in Cancer Research
One of the leading experts in this field is Dr. Sapna Patel, MD, who currently serves as the Chair of SWOG Melanoma Committee at the University of Colorado. She holds the prestigious William Robinson Endowed Chair and is also a Professor in Cancer Research.
Patients diagnosed with high-risk Stage III melanoma could gain advantages from a neoadjuvant approach, where treatment is administered prior to surgical interventions. The objectives of neoadjuvant therapy are to amplify the immune system's response against the tumor and to reduce the size of the tumor. This can lead to a better outcome for the patient, with improved survival rates and potential for long-term remission.
Adjuvant therapy serves as a supplementary treatment administered following the initial treatment of a disease. In the context of melanoma, it is often employed post-surgery to minimize the likelihood of the disease's recurrence. Patients who have undergone surgical procedures for melanoma and are considered at elevated risk for its return may benefit from this approach.
Neoadjuvant therapy is given before surgery and adjuvant therapy is given after surgery. This difference in timing can have a significant impact on the efficacy of the treatment.
Neoadjuvant therapy allows for treatment to be administered while the tumor is still present, which can help to shrink it and make surgical removal easier. It also enables doctors to assess how well a patient responds to a particular treatment, providing valuable information for future treatments.
On the other hand, adjuvant therapy works by targeting any remaining cancer cells after surgery, reducing the risk of recurrence. It may also have a preventative effect by strengthening the immune system against potential future tumors.
While both approaches have their benefits, they also come with their own set of side effects and risks. Neoadjuvant therapy can cause damage to healthy cells, leading to temporary or permanent organ dysfunction. Adjuvant therapy may also have long-term effects on the body, such as increased risk of secondary cancers.
Ultimately, the decision between neoadjuvant and adjuvant therapy depends on a variety of factors, including the type and stage of cancer, overall health of the patient, and potential side effects. It is important for patients to work closely with their medical team to determine the best course of treatment for their specific case.
In addition to traditional chemotherapy drugs, there are also targeted therapies available that specifically target cancer cells while minimizing damage to healthy cells. These treatments are often used in combination with neoadjuvant or adjuvant therapy, providing a more personalized approach to cancer treatment.
It is important for patients to understand that neoadjuvant and adjuvant therapies are not always necessary or beneficial for every type of cancer. In some cases, surgery alone may be enough to effectively treat the cancer, while in others, these additional treatments can greatly improve the chances of a successful outcome.
Neoadjuvant and adjuvant therapies play important roles in cancer treatment by helping to shrink tumors prior to surgery and prevent recurrence after surgery. While they may have their own unique benefits and risks, it is ultimately up to the patient and their medical team to determine the best course of action for their specific case. By staying informed and working closely with their doctors, patients can make the most informed decisions about their cancer treatment.
Переглядів: 85

Відео

Clinical Trial Options - New Data, Future Therapies
Переглядів 115День тому
Ryan J. Sullivan, MD Assistant Professor, Medicine, Harvard Medical School Just over a decade ago, metastatic melanoma was among the cancers with the grimmest prognoses, offering patients a median overall survival of only 6-8 months. The modest response rates of 20%-30% from cytotoxic chemotherapy provided no significant survival advantage, leading to the routine practice of enrolling patients ...
Mucosal, Acral, Uveal Futures - Time to Invest!
Переглядів 49День тому
Inderjit Mehmi, MD Medical Oncology The Angeles Clinic & Research Institute, A Cedars-Sinai Affiliate Melanoma arises from melanocytes, the cells responsible for our unique skin pigmentation. While most melanomas form on sun-exposed skin, they can also appear in less expected places such as the eyes and areas not typically exposed to the sun, like mucous membranes, or even on the palms, soles, ...
Welcome & Introductions
Переглядів 27День тому
As the esteemed Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute, Dr. Omid Hamid dedicates his expertise to ensuring patients have access to the latest therapeutic advances. Recently, within the Phase 1 Developmental Therapeutics Program, Dr. Hamid has played a pivotal role in transitioning new treatments from research to clinical ...
Melanoma Survivorship Panel : Surviving and Thriving
Переглядів 73День тому
Omid Hamid, MD - Chief, Translational Research & Immuno-Oncology, The Angeles Clinic and Research Institute Samantha Guild - President, AIM at Melanoma According to most experts, including the National Cancer Institute, an individual is considered a survivor from the moment they receive a cancer diagnosis, continuing throughout their lifetime. Yet, not everyone diagnosed with melanoma views the...
Radiation Therapy in Melanoma, Novel Paradigms
Переглядів 43День тому
Anthony T. Nguyen, MD PhD Department of Radiation Oncology Cedars-Sinai Medical Center Radiation therapy serves as an effective treatment for melanoma, utilizing a focused beam of high-energy particles aimed at the tumor. This process obliterates cancer cells by inflicting irreparable damage to their DNA. Employed in various capacities, radiation therapy is often recommended post-surgery to for...
Cellular Therapy: TIL Tomorrow and Further
Переглядів 52День тому
Mark B. Faries, MD Co-Director, Melanoma Research Program The Angeles Clinic & Research Institute, A Cedars-Sinai Affiliate Cellular Therapy: TIL Tomorrow and Further for melanoma. Dr. Mark B. Faries is a renowned doctor and researcher in the field of melanoma. As the Co-Director of the Melanoma Research Program at The Angeles Clinic & Research Institute, a Cedars-Sinai affiliate, he has dedica...
Evolution of Immune Intelligent Immunotherapy
Переглядів 79День тому
Omid Hamid, MD Chief, Translational Research & Immuno-Oncology Immunotherapy has revolutionized the landscape of cancer treatment, offering new and effective treatment options for a wide range of solid tumors and blood cancers. While immunotherapy is not a new branch of oncology, it has rapidly evolved into one of the most dynamic and promising areas in medicine. This review article delves into...
ASCO 2024: Advances in Melanoma and Related Cancers
Переглядів 333День тому
In collaboration with the Save Your Skin Foundation, we are excited to share this post-ASCO webinar event. Dr. Omid Hamid, MD, the Chief of Research in Immuno-Oncology at The Angeles Clinic and Research Institute, shares insights and updates from ASCO 2024, with a special focus on melanoma, non-melanoma skin cancers, and ocular/uveal melanoma. The Save Your Skin Foundation is a non-profit organ...
Patient Experience and Resources at Roswell Park
Переглядів 24Місяць тому
When diagnosed with cancer, it can feel as though your life has been turned upside down. Suddenly, your calendar is filled with appointments, scans, tests, and treatments, on top of the emotional toll of grappling with a cancer diagnosis. Feelings of fear, anxiety, and stress can become overwhelming. The battle to survive cancer becomes a central concern, not just for you, but for your loved on...
Behind the Scenes: The Modern Role of Pathology in Melanoma Care
Переглядів 119Місяць тому
Behind the Scenes: The Modern Role of Pathology in Melanoma Care Melanoma is a type of skin cancer that affects millions of people around the world. While it is one of the most common forms of cancer, it can also be one of the deadliest if not caught and treated early. In recent years, there have been significant advancements in the understanding and treatment of melanoma, thanks in part to the...
Strategies for Screening and Prevention of Melanoma
Переглядів 81Місяць тому
Strategies for Screening and Prevention of Melanoma Melanoma is a type of skin cancer that develops in the cells responsible for producing melanin, the pigment that gives color to our skin. It is typically caused by exposure to UV radiation from the sun or tanning beds. Early detection and prevention are crucial in reducing the risk of developing melanoma. Here are some strategies that can help...
The Evolving Role of Surgery in Melanoma Management
Переглядів 222Місяць тому
The Evolving Role of Surgery in Melanoma Management As technology continues to advance and our understanding of cancer grows, the role of surgery in treating melanoma has evolved. In the past, surgery was often viewed as the primary treatment option for melanoma, with chemotherapy or radiation used as adjuvant therapies. However, with the emergence of targeted and immunotherapies, surgery is no...
The Melanoma Printer for Patients
Переглядів 124Місяць тому
Ben Switzer, DO, MHSA, MS Assistant Professor of Oncology, Department of Medicine Diagnosing Melanoma: A Detailed Process Melanoma diagnosis often begins after the removal and pathological examination of a suspicious lesion or mole, which is then confirmed as cancerous. This critical step, known as a biopsy, entails either partially or completely excising the lesion or mole for microscopic inve...
Systemic Therapy for Metastatic Melanoma: State of the Art in 2024
Переглядів 179Місяць тому
Systemic Therapy for Metastatic Melanoma Treatment: Metastatic melanoma is a type of skin cancer that has spread to other parts of the body. It is a serious and potentially life-threatening condition, as it can be difficult to control and treat once it has spread. Systemic therapy is the primary treatment for stage IV melanoma, which is cancer that has spread to other parts of the body. Systemi...
Mole or Monster: Recognizing Melanoma
Переглядів 175Місяць тому
Mole or Monster: Recognizing Melanoma
Opening Remarks at UPMC Hillman Cancer Center Symposium
Переглядів 863 місяці тому
Opening Remarks at UPMC Hillman Cancer Center Symposium
Can We Predict Who Will Respond to Immunotherapy?
Переглядів 1,2 тис.3 місяці тому
Can We Predict Who Will Respond to Immunotherapy?
Pediatric Melanoma: The Time is Now for a Standard Treatment Approach
Переглядів 2253 місяці тому
Pediatric Melanoma: The Time is Now for a Standard Treatment Approach
Preventing Melanoma: How to Protect Your Skin
Переглядів 1113 місяці тому
Preventing Melanoma: How to Protect Your Skin
The Impact of Diet & Gut Microbiota in Determining Response & Immune-Related Adverse Events (IRAEs)
Переглядів 2613 місяці тому
The Impact of Diet & Gut Microbiota in Determining Response & Immune-Related Adverse Events (IRAEs)
Melanoma Tissue Banking-Samples Are Only Part of the Bank-What About the Data?
Переглядів 643 місяці тому
Melanoma Tissue Banking-Samples Are Only Part of the Bank-What About the Data?
Management of Side Effects for BRAF/MEK Inhibitors for Melanoma
Переглядів 3073 місяці тому
Management of Side Effects for BRAF/MEK Inhibitors for Melanoma
Do Oncolytic Viruses Work?
Переглядів 1324 місяці тому
Do Oncolytic Viruses Work?
What Types of Cancer Can Be Treated with Oncolytic Virus Therapy?
Переглядів 1224 місяці тому
What Types of Cancer Can Be Treated with Oncolytic Virus Therapy?
Which Oncolytic Viruses are the most useful and are they natural?
Переглядів 794 місяці тому
Which Oncolytic Viruses are the most useful and are they natural?
How Do Oncolytic Viruses Kill Cancer Cells?
Переглядів 784 місяці тому
How Do Oncolytic Viruses Kill Cancer Cells?
What Are the Side Effects of Oncolytic Virus Therapy?
Переглядів 724 місяці тому
What Are the Side Effects of Oncolytic Virus Therapy?
Are Oncolytic Viruses Dangerous?
Переглядів 314 місяці тому
Are Oncolytic Viruses Dangerous?
What Oncolytic Viruses Are FDA Approved?
Переглядів 1764 місяці тому
What Oncolytic Viruses Are FDA Approved?

КОМЕНТАРІ

  • @owentafadzwamapetere7672
    @owentafadzwamapetere7672 День тому

    thank you

  • @Trang-A-Lang
    @Trang-A-Lang День тому

    How painful is it if you deny treatment?

  • @jonetyson
    @jonetyson 8 днів тому

    I hope you guys get Dr. Weber to repeat his ASCO 2024 talk on Moderna & Merck's Individualized Neoantigen Therapy. It is annoying that ASCO has kept these exciting developments behind a paywall.

  • @dianesilverstein6475
    @dianesilverstein6475 8 днів тому

    On Friday, 6/21/24, I received a diagnosis of uveal melanoma from Retina Consultants of Texas. I am getting a second opinion from MD Anderson (both facilities are in Houston, TX). Luckily for me, my optometrist saw the "freckle" during a routine exam and referred me to their ophthalmologist, who referred me to Dr. Amy Schefler (Ocular Oncologist) at the Retina Consultants of Texas. This is definitely an uneasy time for me and my family. This video was helpful in clarifying the cancer, and treatments available. Are there other resources you'd suggest? Thank you.

  • @DRJHNEWMAN
    @DRJHNEWMAN 13 днів тому

    All of interest.

  • @jonetyson
    @jonetyson 14 днів тому

    Prof. Weber has fallen into misconception #1 of what the p-value is in Steve Goodman's paper "A dirty dozen: twelve p-value misconceptions" PMID: 18582619. From the paper "The definition of the P value is as follows-in words: The probability of the observed result, plus more extreme results, if the null hypothesis were true...The null hypothesis will be defined as the hypothesis that there is no effect of the intervention.... Misconception #1: If P .05, the null hypothesis has only a 5% chance of being true. This is, without a doubt, the most pervasive and pernicious of the many misconceptions about the P value. It perpetuates the false idea that the data alone can tell us how likely we are to be right or wrong in our conclusions. The simplest way to see that this is false is to note that the P value is calculated under the assumption that the null hypothesis is true. It therefore cannot simultaneously be a probability that the null hypothesis is false. Let us suppose we flip a penny four times and observe four heads, two-sided P .125. This does not mean that the probability of the coin being fair is only 12.5%. The only way we can calculate that probability is by Bayes’ theorem, to be discussed later and in other chapters in this issue of Seminars in Hematology" The paper goes on to say "The most important foundational issue to appreciate is that there is no number generated by standard methods that tells us the probability that a given conclusion is right or wrong."

  • @JW4REnvironment
    @JW4REnvironment 17 днів тому

    Many thanks to St. John’s Providence and Dr. Fluke for informing the public regarding treatments for melanoma and why the incision may appear to be on the long side to us lay viewers! This is very informative!

  • @katehagno1184
    @katehagno1184 20 днів тому

    Thank you so much for enhancing my knowledge. Mucosal vag. melanoma at stage 1 - but offered treatment for 2-3 stage conservative opp....which i refused firmly.

  • @Joyjoy-ih1ie
    @Joyjoy-ih1ie 21 день тому

    Eat A LOT of mini sweep peppers, especially red. FULL of vitamin C. Eat them like apples. No food in a box. Broccoli and chicken. Green Bell peppers. Ginger, cucumber, lemon, lime, parsley. Oregano.

  • @calmrestored6031
    @calmrestored6031 28 днів тому

    Thank you for this information which I haven’t found elsewhere.

  • @sophiegoss8378
    @sophiegoss8378 29 днів тому

    I had my surgery a week ago wide excision and lymph nodes removed. They said I was an unusual case they do not normally remove all the nodes without proof but both the ct scan and pet scan showed enlarged nodes and they did try biopsy the nodes but this was negative but they said in there experience based on scans more likely to be positive so better to remove them so that is what happened. Still waiting for the results but when I saw the surgeon afterwards she said it was probably right to remove them.

  • @dennisvr6
    @dennisvr6 Місяць тому

    What is the dosage of the ipi + nivo combination that you use?

  • @victoriadolton4762
    @victoriadolton4762 Місяць тому

    I have dealt with squamous cell CA for three years, but this week I was diagnosed with a large mass in my right eye that's Melanoma. I am going to be tested in a couple of days to see if it has metastasized. Eye removal and radiation have been discussed.

  • @victoriadolton4762
    @victoriadolton4762 Місяць тому

    Today I was diagnosed with a large mass in my right eye. It is melanoma. I will have to have more testing in a few days to see if it has spread. I have been followed for squamous cell cancer and have had MOHS surgeries, besides topical chemo for precancerous areas for my legs, chest, arms and face.

  • @thunderdragon888
    @thunderdragon888 Місяць тому

    Besides screening, can CRP test be another strong indication of any malognancy taking place ?

  • @robertmontgomery6256
    @robertmontgomery6256 Місяць тому

    Yikes! Isn’t Til the “nuclear option”? Is it used only as a post front line Rx? Not for everyone, right?

  • @artbyfaith
    @artbyfaith Місяць тому

    My son has Stage 4 metastatic melanoma. He’s getting optivo and Yervoy, but I’m not sure it’s working. The tumor is localized in his left side of his neck. HELP!

  • @user-jy4mw3um7v
    @user-jy4mw3um7v Місяць тому

    😢😢😢😢😢😢

  • @garyfratus3640
    @garyfratus3640 Місяць тому

    Love how positive they are.

  • @911_TruthNow
    @911_TruthNow Місяць тому

    making the sick person sicker and that is called curing the disease. That is sick.

  • @oxxxeee
    @oxxxeee 2 місяці тому

    💯❣

  • @santoinetteberger
    @santoinetteberger 2 місяці тому

    At 5 min 18 sec did you say Melanoma is the most common form of skin cancer? I read Basal Cell was. Melanoma is only 1%. Maybe i misunderstood you?

  • @lavender4247
    @lavender4247 2 місяці тому

    Thank you so much for explaining so appreciated

  • @dar7230
    @dar7230 2 місяці тому

    You all approached me re:volunteer participation in tissue study. I chose not to participate because the idea of part of me being tested etc makes me very uncomfortable. I cannot settle with that

  • @AuroraCalvo970
    @AuroraCalvo970 2 місяці тому

    Thank you so much. I am so grateful And I pray that God continues to bless you I really appreciate you Dr Emovon on UA-cam for restoring my health, for giving me a permanent cure to my cancer virus #dremovon....

  • @DM-eq8vz
    @DM-eq8vz 2 місяці тому

    You are a calming force Claire Casselman, thank you! (you should do a meditation/breathing/mindful-type channel, or podcast etc...youre very skilled at it. Thanks again ♥

  • @mahalaxmisharma7323
    @mahalaxmisharma7323 2 місяці тому

    Amazing work ! Dr. Alison🎉

  • @dennisvr6
    @dennisvr6 2 місяці тому

    how do you spell the name of the drug mentioned at 24:45 mark? thoraxin or coraxin?

  • @user-dy5ev6kn7g
    @user-dy5ev6kn7g 3 місяці тому

    (•)(•) 🎉 this is ground breaking, how does this not have a thousand 🎉🎉comments? This is a situation that everyone should be following. Leaving a . or a * Because god bless women and Gofd bless their TaTa’s (•)(•)

  • @4seasonenduro527
    @4seasonenduro527 3 місяці тому

    Going to start on Immunotherapy very soon, is there any way to help or participate in these studies? stage IV recurrent melanoma.

  • @4seasonenduro527
    @4seasonenduro527 3 місяці тому

    Stage IV starting immunotherapy within the week. Predictive bio marker would sure make the treatment done with more confidence. I am 27 i hope that with the unknown the gamble will pay off.

  • @nathalievogel7536
    @nathalievogel7536 3 місяці тому

    So interesting ! Thank you a lot for the informations.

  • @williambanzhof9739
    @williambanzhof9739 3 місяці тому

    EXCELLENT! Thanks for presenting!

  • @ivansmart8536
    @ivansmart8536 3 місяці тому

    No it can't

  • @Lisa_BisaRN
    @Lisa_BisaRN 3 місяці тому

    Unfortunately had to stop listening because of all the constant "Um"'s. Um, um, um...

  • @mz-dz2yn
    @mz-dz2yn 3 місяці тому

    any way to participate w bio marker technology companies in trails? is it in same clinical trail system as treatments? are bio marker technology available and used in 100s of countries or only in wealthy places?

  • @mz-dz2yn
    @mz-dz2yn 3 місяці тому

    bio marker technology - costs and broadness of bandwidth of test ? any bio marker technology stands out as future

  • @mz-dz2yn
    @mz-dz2yn 3 місяці тому

    The average person is exposed to ionizing radiation from various sources, including: Natural Background Radiation: This includes radiation from sources such as cosmic rays from outer space, radioactive materials in the Earth's crust, and radon gas that seeps into buildings from the ground. Medical Procedures: Diagnostic medical procedures such as X-rays, CT scans, and nuclear medicine exams can expose individuals to ionizing radiation. Radiation therapy for cancer treatment is another source of exposure. Consumer Products: Some consumer products, such as smoke detectors (which contain small amounts of radioactive material) and certain building materials, may emit low levels of ionizing radiation. Air Travel: Cosmic radiation exposure increases at higher altitudes, so frequent air travelers may receive slightly higher doses of ionizing radiation. The average annual dose of ionizing radiation received by the general population from natural background sources is estimated to be around 3 millisieverts (mSv) globally. However, this can vary depending on factors such as location, altitude, and lifestyle. For medical exposures, the average annual dose from diagnostic procedures is typically much lower, around 0.4 mSv per person in the United States. However, this can vary widely depending on the type and frequency of medical imaging procedures a person undergoes. Over a lifetime, the cumulative dose of ionizing radiation from all sources is estimated to be around 100 to 150 mSv for the average person. Again, this can vary depending on individual factors such as medical history and occupation. It's important to note that while ionizing radiation exposure is inevitable and occurs naturally, efforts should be made to minimize unnecessary exposure, particularly from medical procedures. Medical imaging procedures should be justified based on their potential benefits and risks, and dose optimization techniques should be employed to minimize radiation exposure while maintaining diagnostic accuracy. Overall, while ionizing radiation exposure is a part of everyday life, the doses received by the average person are typically low and unlikely to cause immediate health effects. However, it's essential to be aware of sources of radiation exposure and to take appropriate precautions to minimize unnecessary exposure whenever possible. The unit "mSv" stands for millisievert, which is a measurement of the biological effect of ionizing radiation on human tissue. Sievert (Sv) is the standard unit of dose equivalent, and one millisievert (mSv) is equal to one thousandth of a sievert. The sievert is used to quantify the potential health risks associated with exposure to ionizing radiation, taking into account the type of radiation, its energy, and the sensitivity of the irradiated tissue. It accounts for the fact that different types of radiation (e.g., X-rays, gamma rays, alpha particles) have different biological effects on the body. To put the concept into context, here are some examples of typical radiation doses: Background Radiation: The average annual dose of background radiation received by a person from natural sources is approximately 3 mSv globally. This includes radiation from cosmic rays, radioactive materials in the Earth's crust, and radon gas. Medical Procedures: The radiation dose from medical imaging procedures such as X-rays, CT scans, and nuclear medicine exams can vary widely depending on the type of procedure and the body part being imaged. For example, a chest X-ray may result in a dose of about 0.1 mSv, while a CT scan of the abdomen and pelvis may result in a dose of several millisieverts. Occupational Exposure: Workers in certain occupations, such as nuclear power plant workers, radiology technicians, and airline crew members, may receive higher radiation doses as part of their job duties. However, strict regulations and safety measures are in place to minimize occupational radiation exposure and ensure worker safety. Nuclear Accidents: In the event of a nuclear accident or radiation emergency, individuals in the vicinity may be exposed to higher levels of radiation, potentially resulting in doses that exceed typical background levels. In such situations, prompt evacuation and protective measures are essential to minimize radiation exposure and prevent adverse health effects. It's important to note that while radiation exposure is a part of everyday life, the health risks associated with low levels of radiation are generally considered to be low. However, the cumulative effects of repeated or prolonged exposure to radiation, especially at higher doses, can increase the risk of certain health effects, including cancer and other radiation-related illnesses. Overall, the concept of millisieverts provides a standardized way to measure and compare radiation doses, helping to inform decisions about radiation safety and risk management in various contexts.

  • @mz-dz2yn
    @mz-dz2yn 3 місяці тому

    is any lessening of side effects based on dose seen, is min. effective dose too elevated, can BRAF/MEK Inhibitors be admin at very very low dose and over week or two slowly ramp up to full dose? can dose be every other day every third day, effect on efficacy and side effects???? and end points.... can one be introduced at a time ramped up adding second a week later? one dose one day wait 7 days two doses over two days wait 7 days 3 doses etc etc till every day is it ever been tried? effect on efficacy and side effects???? and end points.

  • @lilspnce49
    @lilspnce49 3 місяці тому

    Thank you for the live stream and all the information. I am stage 3 a and am being treated at the University of Wisconsin in Madison.

  • @agcccggrr
    @agcccggrr 3 місяці тому

    Amtagvi needs to be indicated first line.

    • @SpiritualSchmuck
      @SpiritualSchmuck 3 місяці тому

      They have first line trial study with Keytruda I believe and oncologists are over the moon about this.

  • @codingdevchannel1390
    @codingdevchannel1390 3 місяці тому

    Why it is not working 100 percent

    • @tobbie33
      @tobbie33 3 місяці тому

      name a medication that works 100%

  • @Lisa_BisaRN
    @Lisa_BisaRN 3 місяці тому

    Fascinating!

  • @MartyinPS
    @MartyinPS 3 місяці тому

    Thanks for explaining all the stages. I'd never get that much out of a Dr visit. Found out I have a melanoma on my back and doing a Sentinal biopsy as well. Thanks for clarifying all this. For me this started with a biopsy last Aug 2023 and has taken this long, finally a surgery date in March 2024. 🙂

  • @niladrigouribiswas9297
    @niladrigouribiswas9297 3 місяці тому

    I am stage 4 melanoma patient from India . Please help me.

  • @itechfive240
    @itechfive240 3 місяці тому

    I can't believe these two would be pushing a mRNA vaccine after the disaster of the covid jab. They don't even mention sugar and glutamine as the only fuel used by cancer cells. I guess there's no money in that so who cares? Immunotherapy looks promising

  • @gregsteeves1733
    @gregsteeves1733 4 місяці тому

    I had 2 months of neoadjuvant nivolumab before surgery. During those 2 months, the sizeable lump in my neck from the affected lymph node almost went totally away. When surgery was then performed to remove the nodes in my left neck, there was considerable evidence of necrosis of the tumor. Going into the surgery knowing that the immunotherapy appeared to be working was worth waiting on the surgery because it was encouraging and gave me confidence that the adjuvant treatments (for another 10 months) would clean up anything the surgery didn't get.

  • @ryanhill2774
    @ryanhill2774 4 місяці тому

    10 month stage 4 melanoma survivor- Everything you presented has helped me- would love to hear you discuss limiting salt, hydrogenated oils and unnecessary additives next time. Thanks!

  • @ryanhill2774
    @ryanhill2774 4 місяці тому

    10 month stage 4 survivor -ipilimumab - nivolumab Thanks Doctors❤

  • @airrik2653
    @airrik2653 4 місяці тому

    God help people who believe what this doctor (and others like him) are selling...

    • @sequana42
      @sequana42 4 місяці тому

      Could you elaborate on what you mean?

    • @airrik2653
      @airrik2653 4 місяці тому

      @@sequana42 well for one, he praised great success of covid vaccines...🙃